Sitagliptin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sitagliptin and local guidelines before prescribing.
DPP-4 inhibitor
Mechanism
DPP-4 inhibitor.
Uses
Type 2 diabetes.
Dosing
- Sitagliptin 100 mg daily (reduce in renal impairment).
Endocrinology: Diabetes - Sitagliptin / linagliptin Type 2 | Sitagliptin 100 mg daily (reduce in CKD). Linagliptin 5 mg daily (no renal adjustment). Not with GLP-1 agonists.
Endocrinology: Diabetes
Side effects
Nasopharyngitis, headache, pancreatitis (rare), arthralgia, bullous pemphigoid.
Interactions
Digoxin levels may rise.
Contraindications and cautions
Pancreatitis history
Monitoring
HbA1c, renal function
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Reduce dose with renal impairment.
More from the textbook: uses, cautions and other points
- Sitagliptin / linagliptin | DPP-4; weight neutral, few hypos; pancreatitis, bullous pemphigoid.
Endocrine: Anatomy Physiology and Pharmacology - 80-year-old with itch then tense blisters on the thighs; on sitagliptin | Bullous pemphigoid (gliptin-associated)
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - 3. An 82-year-old woman in a care home has had intense itch for 2 months, and now has large tense blisters on her thighs and abdomen. Her mouth is normal. She takes sitagliptin. Answer: Bullous pemphigoid (possibly gliptin-related).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Stop sitagliptin; very potent topical steroid to the whole body, or doxycycline, or oral prednisolone if severe (with bone and gastric protection).
Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies - Tense blisters on itchy plaques in an 85-year-old on sitagliptin | Bullous pemphigoid
Clinical Immunology: Autoimmunity, autoantibodies and complement